A wealth of clinical evidence has also revealed that elevated serum levels of YKL-40 in GBM are positively correlated with cancer invasiveness, radioresistance, recurrence, and reduced patient survival times [19–25]. The gene discussed is CHI3L1; the disease is cancer.